Aptamer Group to host webinar and Q&A session for investors

Aptamer Group plc (LON: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced that Dr Arron Tolley, Chief Executive Officer and Dr David Bunka, Chief Scientific Officer will be hosting a webinar on Thursday, 12 December 2024 at 6.00 pm (GMT).

The webinar will provide investors with a valuable opportunity to interact with Aptamer Group and gain insights into recent announcements.

There will be a Q&A session for investors after the presentation and questions can be submitted pre-event as part of the registration process.

You can register for the event by using the following link:

https://www.turnerpope.com/register

We are delighted to announce that the webinar will be chaired by experienced news and corporate events presenter Katie Pilbeam (www.katiepilbeam.com) and hosted by the Company’s broker, Turner Pope Investments.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Aptamer Group

    More articles like this

    Aptamer Group

    Aptamer Group secures new contracts worth up to £471,000

    Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has provided an update on contracts signed since its financial year ended 30 June 2024. Aptamer has secured new contracts

    Aptamer Group

    Aptamer making significant progress commercially and technically

    Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced its full year results for the twelve months ended 30 June 2024. Highlights ·      New strategic approach launched in August

    Aptamer Group

    Aptamer Group appoints Tim Sykes as a Non-Executive Director

    Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced the appointment of Tim Sykes to its Board of Directors as a Non-Executive Director with immediate effect. Tim